Syra Health Corp. (SYRA)

0.842 0.00 (0.00%) USD  |  OTCM  |  Oct 15, 16:00
More

Syra Health Research and Development Expense (Quarterly) : 0.0474M for June 30, 2026

Research and Development Expense (Quarterly) Chart

Historical Research and Development Expense (Quarterly) Data

View and export this data back to 2023. Start Trial.
Date Value
June 30, 2026 0.0474M
March 31, 2026 0.0069M
December 31, 2025 0.0001M
September 30, 2025 0.0008M
June 30, 2025 0.0297M
March 31, 2025 0.0372M
Date Value
December 31, 2024
September 30, 2024 0.0348M
June 30, 2024 0.2779M
March 31, 2024 0.2775M
December 31, 2023 0.24M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Dogecoin Cash, Inc. --
Privia Health Group, Inc. --
Strata Critical Medical, Inc. 1.006M
BrightSpring Health Services, Inc. --
Cryo-Cell International, Inc. 0.0536M